Using its proprietary FBDD platform, Blacksmith discovered FG-2101, the prodrug form of FG-960, the first known non-hydroxamate LpxC inhibitor that exerted activity against LpxC at the nanomolar range ...

However, weak free cash flow combined with negative momentum in the stock led to shares falling 7% in early trading. We are lowering our fair value estimate 5% to EUR 80 from EUR 84 after ...